| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |